Table 3.
Summary statistics and cost-effectiveness analysis: Simulated data
Mean-based analysis | |||
---|---|---|---|
Treatment | Cost | Cost difference (95% CI) | ICERmean (95% CI) |
A | $426 | $597 (320, 897) | 502 (291, 721) in NE |
B | $1,023 | ||
Effectiveness | Effectiveness difference (95% CI) | ||
A | 5.95 | 1.19 (1.02, 1.36) | |
B | 7.14 | ||
Median-based analysis | |||
Treatment | Cost | Cost difference (95% CI) | ICERmedian (95% CI) |
A | $141 | $49 (−1.06, 88) | 40 (−0.99, 70) in SE/NE |
B | $190 | ||
Effectiveness | Effectiveness difference (95% CI) | ||
A | 5.92 | 1.21 (0.98, 1.38) | |
B | 7.13 |
CI denotes confidence interval. ICER denotes incremental cost-effectiveness ratio.
See Figure 3 for the cost-effectiveness plane and CIs.
500 patients in treatment A and 500 patients in treatment B were included.